The roles of APOBEC3B in gastric cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 5089-5096

  Zhang, Jian ^a   Wei, Wei ^a   Jin, Hui Cheng ^a   Ying, Rong Chao ^a   Zhu, A Kao ^a   Zhang, Fang Jie ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

APOBEC3B; Gastric cancer; PDCD2; Prognosis; Proliferation

Indexed keywords

APOBEC3B PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; ATM PROTEIN; ATM PROTEIN, HUMAN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CHEK2 PROTEIN, HUMAN; CYTIDINE DEAMINASE; MESSENGER RNA; MINOR HISTOCOMPATIBILITY ANTIGEN; PDCD2 PROTEIN, HUMAN; PROTEIN KINASE;

CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; STOMACH TUMOR; TIME FACTOR; TUMOR CELL LINE;

APOPTOSIS REGULATORY PROTEINS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYTIDINE DEAMINASE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; MOLECULAR SEQUENCE DATA; NEOPLASM GRADING; NEOPLASM STAGING; PROTEIN KINASES; RNA INTERFERENCE; RNA, MESSENGER; S PHASE CELL CYCLE CHECKPOINTS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TIME FACTORS; TRANSFECTION;

EID: 84937893632     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X and He J. Annual report on status of can cer in China, 2010. Chin J Cancer Res 2014; 26: 48-58.
2. Conticello SG. The AID/APOBEC family of ucleic acid mutators. Genome Biol 2008; 9: 229.
3. Vieira VC and Soares MA. The role of cytidine deaminases on innate immune responses against human viral infections. Biomed Res Int 2013; 2013: 683095.
4. Koito A and Ikeda T. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front Microbiol 2013; 4: 28.
5. Kidd JM, Newman TL, Tuzun E, Kaul R and Eichler EE. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 2007; 3: e63.
6. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, Law EK and Harris RS. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 2013; 494: 366-370.
7. Burns MB, Temiz NA and Harris RS. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 2013; 45: 977-983.
8. Jin Z, Han YX and Han XR. The role of APOBEC3B in chondrosarcoma. Oncol Rep 2014; 32: 1867-1872.
9. van Jaarsveld MT, Wouters MD, Boersma AW, Smid M, van Ijcken WF, Mathijssen RH, Hoeijmakers JH, Martens JW, van Laere S, Wiemer EA and Pothof J. DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity. Mol Oncol 2013; 8: 458-468.
10. Yellapa A, Bitterman P, Sharma S, Guirguis AS, Bahr JM, Basu S, Abramowicz JS and Barua A. Interleukin 16 expression changes in association with ovarian malignant transformation. Am J Obstet Gynecol 2014; 210: 272, e1-10.
11. Zhang J, Wei W, Jin HC, Ying RC, Zhu AK and Zhang FJ. Programmed cell death 2 protein induces gastric cancer cell growth arrest at the early S phase of the cell cycle and apoptosis in a p53-dependent manner. Oncol Rep 2015; 33: 103-110.
12. Smith GC, Cary RB, Lakin ND, Hann BC, Teo SH, Chen DJ and Jackson SP. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc Natl Acad Sci U S A 1999; 96: 11134-11139.